Greg Barrett

Greg is President of EVOQ Therapeutics, leading capital raising, organizational build-out, and partnering activities for their autoimmune disease therapies. With 30 years of Pharma/Biotech experience, he has developed and launched 10+ brands (several with billion-dollar sales) and held multiple senior roles (US & Global) at Schering-Plough, and Daiichi Sankyo (including President of the $2.8B / 2500 employee US Commercial division).